Javascript must be enabled to continue!
Translocator protein ligand Ro5-4864 promotes melanogenesis in a TSPO independent manner
View through CrossRef
The 18-kDa translocator protein (TSPO) is highly conserved among
different species but with perplexing biochemical function. Multiple
ligands of TSPO show commendable regulatory activities among lots of
biological functions, such as neuroinflammation, cholesterol transport
and so on. These researches support that TSPO may be a potential target
for disease treatment and drug development. Previous studies have shown
that its ligand agonist benzodiazepines have the effect of promoting
melanin, but the specific mechanism is still unclear. In this research,
we firstly confirmed the melanogenesis promotion of Ro5-4864 in mouse
melanoma cell line, human skin tissue and zebrafish embryos through
inducing melanin synthesis and melanosome transport. Molecular genetics
and pharmacological studies showed that TSPO deficiency did not affect
melanin production in B16F10 cells and zebrafish embryos, nor did it
affect melanin promotion effect of Ro5-4864. The expression of lots of
melanogenesis related proteins, such as TYR, TRP-1, DCT, Mlph and Rab27
were upregulated in Ro5-4864 treatment cell with or without Tspo. These
results indicated that Ro5-4864 induced melanogenesis in a TSPO
independent manner. However, further research is still needed to clarify
the direct downstream target of Ro5-4864 in promoting melanogenesis.
Title: Translocator protein ligand Ro5-4864 promotes melanogenesis in a TSPO independent manner
Description:
The 18-kDa translocator protein (TSPO) is highly conserved among
different species but with perplexing biochemical function.
Multiple
ligands of TSPO show commendable regulatory activities among lots of
biological functions, such as neuroinflammation, cholesterol transport
and so on.
These researches support that TSPO may be a potential target
for disease treatment and drug development.
Previous studies have shown
that its ligand agonist benzodiazepines have the effect of promoting
melanin, but the specific mechanism is still unclear.
In this research,
we firstly confirmed the melanogenesis promotion of Ro5-4864 in mouse
melanoma cell line, human skin tissue and zebrafish embryos through
inducing melanin synthesis and melanosome transport.
Molecular genetics
and pharmacological studies showed that TSPO deficiency did not affect
melanin production in B16F10 cells and zebrafish embryos, nor did it
affect melanin promotion effect of Ro5-4864.
The expression of lots of
melanogenesis related proteins, such as TYR, TRP-1, DCT, Mlph and Rab27
were upregulated in Ro5-4864 treatment cell with or without Tspo.
These
results indicated that Ro5-4864 induced melanogenesis in a TSPO
independent manner.
However, further research is still needed to clarify
the direct downstream target of Ro5-4864 in promoting melanogenesis.
Related Results
Abstract 4240: The translocator protein 18kDa in the morphogenesis of breast epithelial cells in 3D culture
Abstract 4240: The translocator protein 18kDa in the morphogenesis of breast epithelial cells in 3D culture
Abstract
Translocator protein (TSPO) is an 18 kDa mitochondrial membrane protein, first identified as a second binding site for benzodiazepine. Elevated levels of TS...
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis
AbstractThe mitochondrial translocator protein (TSPO) has been implicated in CNS diseases. Here, we sought to determine the specific role of TSPO in experimental autoimmune encepha...
Efficacy of TSPO ligands on neuronal damage mediated by LPS-stimulated BV-2 microglial activation
Efficacy of TSPO ligands on neuronal damage mediated by LPS-stimulated BV-2 microglial activation
Abstract
Background
Neuroinflammation mediated by microglia is an important pathological process of neurodegenerative diseases. Alleviating the inflammatory response cause...
Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by TSPO
Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by TSPO
Background The 18kDa Translocator Protein (TSPO) has been proposed as a
novel anti-inflammatory drug target. XBD173 and etifoxine are TSPO
ligands that modulate inflammatory respon...
The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS
The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS
The 18 kDa Translocator Protein (TSPO) is a marker for microglial activation as its expression is enhanced in activated microglia during neuroinflammation. TSPO ligands can attenua...
Toward the functional oligomerization state of tryptophan‐rich sensory proteins
Toward the functional oligomerization state of tryptophan‐rich sensory proteins
AbstractA conserved family of tryptophan‐rich sensory proteins (TspO) mediates the transport of heme degradation intermediates across membranes. In eukaryotes, the homologous mitoc...
Inhibitory Effects of the Two Novel TSPO Ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced Microglial Activation
Inhibitory Effects of the Two Novel TSPO Ligands 2-Cl-MGV-1 and MGV-1 on LPS-induced Microglial Activation
The 18 kDa translocator protein (TSPO) ligands 2-Cl-MGV-1 and MGV-1 can attenuate cell death of astrocyte-like cells (U118MG) and induce differentiation of neuronal progenitor cell...
PET molecular imaging of peripheral and central inflammatory processes targeting the TSPO 18 kDa
PET molecular imaging of peripheral and central inflammatory processes targeting the TSPO 18 kDa
Imagerie Moléculaire du processus inflammatoire périphérique et central par TEP des en ciblant le TSPO 18kDa
L’objectif de la thèse: À ce jour, il est admis que la ...

